[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Hashin Sats [@HashinSats](/creator/twitter/HashinSats) on x XX followers Created: 2025-07-16 21:41:24 UTC 🚨 $SRPT just de-risked Elevidys label + posted a $513M Q2 beat. Analysts were already bullish pre-news: 📊 Avg PT: $XXXXX (+123.7%) 🧠 UBS: $XX (+366%) 🏦 WFC, OpCo, Mizuho: $40–75 Expect upgrades. Expect re-rating. XXX engagements  **Related Topics** [$xbi](/topic/$xbi) [bearish](/topic/bearish) [$513m](/topic/$513m) [$srpt](/topic/$srpt) [sats](/topic/sats) [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc) [stocks healthcare](/topic/stocks-healthcare) [$wfc](/topic/$wfc) [Post Link](https://x.com/HashinSats/status/1945599673672372617)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Hashin Sats @HashinSats on x XX followers
Created: 2025-07-16 21:41:24 UTC
🚨 $SRPT just de-risked Elevidys label + posted a $513M Q2 beat. Analysts were already bullish pre-news: 📊 Avg PT: $XXXXX (+123.7%) 🧠 UBS: $XX (+366%) 🏦 WFC, OpCo, Mizuho: $40–75 Expect upgrades. Expect re-rating.
XXX engagements
Related Topics $xbi bearish $513m $srpt sats sarepta therapeutics inc stocks healthcare $wfc
/post/tweet::1945599673672372617